Impulse control disorders in Parkinson's disease: Recent advances

Current Opinion in Neurology

Volumn 24, Issue 4, 2011, Pages 324-330

  Voon, Valerie ^a   Mehta, Arpan R ^a   Hallett, Mark ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

dopamine agonists; impulse control disorders; impulsivity; Parkinson's disease; pathological gambling

Indexed keywords

LEVODOPA; PRAMIPEXOLE; ROPINIROLE;

ANXIETY; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DOPAMINE RELEASE; DYSKINESIA; HUMAN; IMPULSE CONTROL DISORDER; IMPULSIVENESS; NEUROIMAGING; OBSESSION; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PATHOPHYSIOLOGY; REVIEW; REWARD; RISK FACTOR; TASK PERFORMANCE;

DOPAMINE; HUMANS; IMPULSE CONTROL DISORDERS; MULTICENTER STUDIES AS TOPIC; PARKINSON DISEASE; RECEPTORS, DOPAMINE; REWARD;

EID: 79960785470     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0b013e3283489687     Document Type: Review

References (60)

1. O'Sullivan SS, Djamshidian A, Evans AH, et al. Excessive hoarding in Parkinson's disease. Mov Disord 2010; 25:1026-1033.
2. Bonfanti AB, Gatto EM. Kleptomania, an unusual impulsive control disorder in Parkinson's disease? Parkinsonism Relat Disord 2010; 16:358-359.
3. Bienfait KL, Menza M, Mark MH, Dobkin RD. Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists. J Clin Neurosci 2010; 17:539-540.
4. Voon V, Potenza MN, Thomsen T. Medication-related impulse control and repetitive behaviors in Parkinson's disease. Curr Opin Neurol 2007; 20:484-492. (Pubitemid 47051998)
5. Voon V. Treatment of impulse control disorders in the general population and Parkinson's disease. Exp Opin Pharmacother (in press).
6. Weintraub D, Koester J, Potenza MN, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010; 67:589-595.
7. Avanzi M, Baratti M, Cabrini S, et al. Prevalence of pathological gambling in patients with Parkinson's disease. Mov Disord 2006; 21:2068-2072. (Pubitemid 46140413)
8. Cilia R, Cho SS, van Eimeren T, et al. Pathological gambling in patients with Parkinson's disease is associated with fronto-striatal disconnection: a path modeling analysis. Mov Disord 2011; 26:225-233.
9. Cornelius JR, Tippmann-Peikert M, Slocumb NL, et al. Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study. Sleep 2010; 33:81-87.
10. O'Sullivan SS, Djamshidian A, Ahmed Z, et al. Impulsive-compulsive spectrum behaviors in pathologically confirmed progressive supranuclear palsy. Mov Disord 2010; 25:638-642.
11. Evans AH, Butzkueven H. Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis. Mov Disord 2007; 22:590-591. (Pubitemid 46608168)
12. Wicks P, MacPhee GJ. Pathological gambling amongst Parkinson's disease and ALS patients in an online community (PatientsLikeMe.com). Mov Disord 2009; 24:1085-1088.
13. Ondo WG, Lai D. Predictors of impulsivity and reward seeking behavior with dopamine agonists. Parkinsonism Relat Disord 2008; 14:28-32.
14. Lee JY, Lee EK, Park SS, et al. Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease. Mov Disord 2009; 24:1803-1810.
15. Gallagher DA, O'Sullivan SS, Evans AH, et al. Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series. Mov Disord 2007; 22:1757-1763. (Pubitemid 47597599)
16. Weintraub D, Sohr M, Potenza MN, et al. Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study. Ann Neurol 2010; 68:963-968.
17. Thomas A, Bonanni L, Gambi F, et al. Pathological gambling in Parkinson disease is reduced by amantadine. Ann Neurol 2010; 68:400-404.
18. Voon V, Sohr M, Lang AE, et al. Impulse control disorders in Parkinson disease: a multicenter case-control study. Ann Neurol 2011 [Epub ahead of print].
19. Pontone G, Williams JR, Bassett SS, Marsh L. Clinical features associated with impulse control disorders in Parkinson disease. Neurology 2006; 67:1258-1261. (Pubitemid 44563839)
20. Isaias IU, Siri C, Cilia R, et al. The relationship between impulsivity and impulse control disorders in Parkinson's disease. Mov Disord 2008; 23:411-415.
21. Voon V, Thomsen T, Miyasaki JM, et al. Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Arch Neurol 2007; 64:212-216.
22. Cools R. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease. Neurosci Biobehav Rev 2006; 30:1-23. (Pubitemid 41779404)
23. Thobois S, Ardouin C, Lhommee E, et al. Nonmotor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation. Brain 2010; 133:1111-1127.
24. Bxarone P, Poewe W, Albrecht S, et al. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2010; 9:573-580.
25. Voon V, Fernagut PO, Wickens J, et al. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders. Lancet Neurol 2009; 8:1140-1149.
26. Rodriguez-Oroz MC, Lopez-Azcarate J, Garcia-Garcia D, et al. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease. Brain 2011; 134 (Pt 1):36-49.
27. Silveira-Moriyama L, Evans AH, Katzenschlager R, Lees AJ. Punding and dyskinesias. Mov Disord 2006; 21:2214-2217. (Pubitemid 46140441)
28. Potenza MN. Review. The neurobiology of pathological gambling and drug addiction: an overview and new findings. Philos Trans R Soc Lond B Biol Sci 2008; 363:3181-3189.
29. Rabinak CA, Nirenberg MJ. Dopamine agonist withdrawal syndrome in Parkinson disease. Arch Neurol 2010; 67:58-63.
30. Chernoloz O, El Mansari M, Blier P. Sustained administration of pramipexole modifies the spontaneous firing of dopamine, norepinephrine, and serotonin neurons in the rat brain. Neuropsychopharmacology 2009; 34:651-661.
31. Steeves TD, Miyasaki J, Zurowski M, et al. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain 2009; 132 (Pt 5):1376-1385.
32. Schultz W, Dayan P, Montague PR. A neural substrate of prediction and reward. Science 1997; 275:1593-1599. (Pubitemid 27120526)
33. Frank MJ, Seeberger LC, O'Reilly RC. By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science 2004; 306:1940-1943. (Pubitemid 39627859)
34. Bodi N, Keri S, Nagy H, et al. Reward-learning and the novelty-seeking personality: a between-and within-subjects study of the effects of dopamine agonists on young Parkinson's patients. Brain 2009; 132 (Pt 9):2385-2395.
35. Voon V, Pessiglione M, Brezing C, et al. Mechanisms underlying dopaminemediated reward bias in compulsive behaviors. Neuron 2010; 65:135-142.
36. Djamshidian A, Jha A, O'Sullivan SS, et al. Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease. Mov Disord 2010; 25:2203-2210.
37. Robinson TE, Berridge KC. The neural basis of drug craving: an incentivesensitization theory of addiction. Brain Res Brain Res Rev 1993; 18:247-291. (Pubitemid 23219500)
38. O'Sullivan SS, Wu K, Politis M, et al. Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours. Brain 2011; 134:969-978.
39. Frosini D, Pesaresi I, Cosottini M, et al. Parkinson's disease and pathological gambling: results from a functional MRI study. Mov Disord 2010; 25:2449-2453.
40. Volkow ND, Wang GJ, Telang F, et al. Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci 2006; 26:6583-6588. (Pubitemid 44318339)
41. Housden CR, O'Sullivan SS, Joyce EM, et al. Intact reward learning but elevated delay discounting in Parkinson's disease patients with impulsivecompulsive spectrum behaviors. Neuropsychopharmacology 2010; 35:2155-2166.
42. Preuschoff K, Bossaerts P, Quartz SR. Neural differentiation of expected reward and risk in human subcortical structures. Neuron 2006; 51:381-390. (Pubitemid 44160540)
43. Voon V, Gao J, Brezing C, et al. Dopamine agonists and risk: impulse control disorders in Parkinson's disease. Brain 2011; 134 (Pt 5):1438-1446.
44. Rao H, Mamikonyan E, Detre JA, et al. Decreased ventral striatal activity with impulse control disorders in Parkinson's disease. Mov Disord 2010 [Epub ahead of print].
45. van Eimeren T, Pellecchia G, Cilia R, et al. Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD. Neurology 2010; 75:1711-1716.
46. Eagle DM, Baunez C. Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition. Neurosci Biobehav Rev 2010; 34:50-72.
47. Voon V, Reynolds B, Brezing C, et al. Impulsive choice and response in dopamine agonist-related impulse control behaviors. Psychopharmacology (Berl) 2010; 207:645-659.
48. Frank MJ, Samanta J, Moustafa AA, Sherman SJ. Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science 2007; 318:1309-1312. (Pubitemid 350172897)
49. Dalley JW, Fryer TD, Brichard L, et al. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 2007; 315: 1267-1270. (Pubitemid 46364262)
50. Evans AH, Pavese N, Lawrence AD, et al. Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann Neurol 2006; 59:852-858. (Pubitemid 43673163)
51. Djamshidian A, O'Sullivan SS, Doherty K, et al. Altruistic punishment in patients with Parkinson's disease with and without impulsive behaviour. Neuropsychologia 2011; 49:103-107.
52. Santangelo G, Vitale C, Trojano L, et al. Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease. Mov Disord 2009; 24:899-905.
53. Siri C, Cilia R, De Gaspari D, et al. Cognitive status of patients with Parkinson's disease and pathological gambling. J Neurol. 2010; 257:247-252.
54. Bordet R, Ridray S, Carboni S, et al. Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa. Proc Natl Acad Sci USA 1997; 94:3363-3367. (Pubitemid 27157317)
55. Weintraub D, Hoops S, Shea JA, et al. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Mov Disord 2009; 24:1461-1467.
56. Papay K,Mamikonyan E, Siderowf AD, et al. Patient versus informant reporting of ICD symptoms in Parkinson's disease using the QUIP: validity and variability. Parkinsonism Relat Disord 2011; 17:153-155.
57. Mamikonyan E, Siderowf AD, Duda JE, et al. Long-term follow-up of impulse control disorders in Parkinson's disease. Mov Disord 2008; 23:75-80. (Pubitemid 351281221)
58. Ardouin C, Voon V, Worbe Y, et al. Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation. Mov Disord 2006; 21:1941-1946. (Pubitemid 44848942)
59. Lim SY, O'Sullivan SS, Kotschet K, et al. Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease. J Clin Neurosci 2009; 16:1148-1152.
60. Voon V, Krack P, Lang AE, et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 2008; 131 (Pt 10):2720-2728.